The clinical studies will be conducted at the ISCI facility in the Hospital Galenia in Cancun, Mexico and will consist of an integrative approach that will combine autologous, adult progenitor cells with physical therapy, nutrition and other complementary treatments to multiple sclerosis , Alzheimer's and Parkinson's disease.
http://www.marketwire.com/press-release/yafarm-technologies-announces-isci-clinical-study-pinksheets-yfrm-1760623.htm
http://www.marketwire.com/press-release/yafarm-technologies-announces-isci-clinical-study-pinksheets-yfrm-1760623.htm
No comments:
Post a Comment